M&A

Did Johnson & Johnson Just Spit in Alphabet's Face?
Did Johnson & Johnson Just Spit in Alphabet's Face?
Motley Fool
JNJ
Alphabet
Auris Health
robotic surgery
M&A
Verb Surgical
Flag link:
Charles River swoops on early-stage CRO Citoxlab
Charles River swoops on early-stage CRO Citoxlab
Fierce Biotech
Charles River Labs
M&A
Citoxlab
CROs
R&D
Flag link:
J&J to enter the robotic surgery market with $3.4B Auris Health buy
J&J to enter the robotic surgery market with $3.4B Auris Health buy
Mass Device
JNJ
robotic surgery
Ethicon
M&A
Auris Health
Flag link:
This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why
This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why
Investors Business Daily
uniQure
M&A
hemophilia B
AMT-061
Pfizer
Spark Therapeutics
Flag link:
Bristol-Myers' rumored activists 'haven't made a decision' on the company yet: Starboard CEO
Bristol-Myers' rumored activists 'haven't made a decision' on the company yet: Starboard CEO
Fierce Pharma
Bristol-Myers Squibb
Celgene
M&A
Starboard
Jeff Smith
Flag link:
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
TheStreet.com
Eli Lilly
earnings
M&A
Loxo Oncology
Flag link:
Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day
Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day
Fierce Pharma
Gilead Sciences
Daniel O'Day
M&A
Pharma CEOs
Flag link:
Starboard Value Is to Take Stake in Bristol-Myers Squibb
Starboard Value Is to Take Stake in Bristol-Myers Squibb
Bloomberg
Bristol-Myers Squibb
Celgene
M&A
Starboard
Jeff Smith
Flag link:
Bristol-Myers yanked its Celgene bid days before deadline—and got a better price
Bristol-Myers yanked its Celgene bid days before deadline—and got a better price
Fierce Pharma
M&A
Bristol-Myers Squibb
Celgene
Flag link:
Eli Lilly Loxo Oncology Transaction Clears A Hurdle
Eli Lilly Loxo Oncology Transaction Clears A Hurdle
CP Wire
Eli Lilly
Loxo Oncology
M&A
Flag link:
Eli Lilly Loxo Oncology Transaction Clears A Hurdle
Eli Lilly
Loxo Oncology
M&A
Flag link:
What’s BMS saying about its Celgene buy behind the scenes? This transcript tells all
What’s BMS saying about its Celgene buy behind the scenes? This transcript tells all
Fierce Pharma
M&A
Celgene
Bristol-Myers Squibb
Flag link:
Amgen hunts for deals of all sizes to combat forthcoming sales decline
Amgen hunts for deals of all sizes to combat forthcoming sales decline
Fierce Pharma
Amgen
earnings
M&A
Flag link:
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Bristol-Myers Squibb's Q4 Earnings Update Shows Why It Needs Celgene
Bristol-Myers Squibb's Q4 Earnings Update Shows Why It Needs Celgene
Motley Fool
Bristol-Myers Squibb
earnings
M&A
Celgene
Flag link:
What Should Digital Health Learn From Propeller Health's $225 Million Acquisition
What Should Digital Health Learn From Propeller Health's $225 Million Acquisition
Forbes
ResMed
Propeller Health
M&A
Flag link:
Medtronic to acquire cardiac ablation tech dev Epix Therapeutics
Medtronic to acquire cardiac ablation tech dev Epix Therapeutics
Mass Device
Medtronic
Epix Therapeutics
Advanced Cardiac Therapeutics
devices
M&A
Flag link:
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Forbes
Abbott Labs
Pharma CEOs
Miles White
M&A
Flag link:
J&J may nab surgical robotics company Auris Health
J&J may nab surgical robotics company Auris Health
Mass Device
devices
M&A
JNJ
Auris Health
robotic surgery
Flag link:

Pages